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Background: The extent that the prognostic value of exercise capacity is influenced by gender or statin therapy in patients with dyslipidemia is 
unclear.
methods: This mixed prospective/retrospective cohort study included 30,352 patients with dyslipidemia (57 ± 12 years old, 55% men, 24% black) 
who underwent physician-referred treadmill stress testing at the Henry Ford Hospital from 1991-2009. Patients were stratified by gender, baseline 
statin therapy, and estimated metabolic equivalents (METS) from stress testing (<6, 6-10, 10-12, or >12). We computed hazard ratios (HR) using Cox 
regression models after adjusting for cardiac risk factors, comorbidities, pertinent medications, interaction terms, and indication for testing.
results: There were 4,283 all-cause deaths, and 3,382 composite myocardial infarctions and revascularizations over a mean follow-up of 10.5 
± 4 years. Men and women not on statin therapy, and men and women on statin therapy, achieved mean METS of 10.1, 8.2, 9.0, and 7.3, and had 
mortality at median follow-up of 8%, 7%, 15% and 11%, respectively (p < 0.01 for all). Higher strata of exercise capacity were associated with lower 
adjusted HR in all statin-gender groups (p < 0.01) [Figure], with no interaction with statin therapy (p > 0.14).
conclusion: Higher exercise capacity attenuated risk for mortality and other adverse outcomes independent of gender and statin therapy in 
dyslipidemic patients seen in clinical practice, reinforcing its importance in all patients with dyslipidemia.
 
